Search results
Earnings call: BioNTech targets oncology growth, plans new COVID vaccine By Investing.com
Investing.com· 6 days agoBioNTech SE (NASDAQ:BNTX), a biotechnology company, reported its first-quarter financial results for...
We Discuss Why BioNTech SE's (NASDAQ:BNTX) CEO Will Find It Hard To Get A Pay Rise From Shareholders...
Simply Wall St. via Yahoo Finance· 1 day agoKey Insights BioNTech will host its Annual General Meeting on 17th of May CEO Ugur Sahin's total...
BioNTech shares hold rating, price target raised By Investing.com
Investing.com· 5 days agoTuesday, BioNTech SE (NASDAQ:BNTX) shares maintained their Hold rating, but with an updated price...
Cracking The Code: Understanding Analyst Reviews For BioNTech - BioNTech (NASDAQ:BNTX)
Benzinga· 5 days agoDebt Management: BioNTech's debt-to-equity ratio is below the industry average at 0.01 , reflecting a lower dependency on debt financing and a more conservative financial.
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 3 days agoThe company is a leader in the neuroscience space. Neurocrine recently asked the Food and Drug...
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg via Yahoo Finance· 2 days ago(Bloomberg) -- Novavax Inc. shares surged after the company signed a $1.2 billion licensing...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 4 days agoSo, all in all, is PFE stock a buy or a sell right now? Pfizer Stock Fundamentals: 'Massive' Upside...
Novavax Stock Surges 140% on $1.4 Billion Deal With Sanofi
Barrons.com· 2 days agoNovavax the pharmaceutical company that last year warned that falling sales of its Covid-19 vaccine...
Disney steps up as Big Tech steps back: What to know this week
Yahoo Finance· 7 days agoWith the peak of first quarter earnings season in the rearview, stocks got back to their winning...
Vertex Beats Quarterly Forecasts, But Its Pipeline Remains Key
Investor's Business Daily· 6 days agoAlthough Vertex Pharmaceuticals (VRTX) is the de facto leader of the market for cystic fibrosis...